logo image
search icon
Digital Vaccine Market

Digital Vaccine Market Size, Share & Trends Analysis Report By Device Type (Smartphone, Tablets, Others), Application (Diabetes, Infectious Diseases, Cardiovascular Diseases, Others), By Region, And Segment Forecasts, 2024-2031

Report ID : 1708 | Published : 2024-06-17 | Pages: 180 | Format: PDF/EXCEL

The Global Digital Vaccine Market Size is valued at 1.61 billion in 2023 and is predicted to reach 3.73 billion by the year 2031 at a 11.25% CAGR during the forecast period for 2024-2031.

Digital Vaccines are a subset of digital therapeutics. Digital vaccines deploy applications on smartphones, tablets, and other similar devices for neurocognitive training to promote positive human behavior. The breakthrough in vaccine creation resulted recently with digital vaccines, which allowed for the developing antigens to utilize their molecular structure, commonly in conjunction with antibodies and made it feasible to create synthetic genes and deliver them as mRNAs. 

https://www.insightaceanalytic.com/images_data/405150644.JPG

Digital therapeutics rapid technological development is accelerating the digital vaccine market expansion. The industry is further escalating due to advancements in digital vaccines like the Internet of Things (IoT), wearable technology, metaverse platforms, and Augmented Reality (AR/VR).

Digital vaccine Market demand is anticipated to be impacted by factors such as the growing population, increased research and developments activities, rise in the number of individuals suffering from different diseases, improved collaboration with progressive governments, and acceptable funders and investors.

Several other vital global factors impacting the growth of the digital vaccine market are data privacy laws and the growing use of digital vaccinations in the healthcare industry. Another significant factor affecting the digital vaccine market growth rate is the rising healthcare expense, which helps build its infrastructure. 

Recent Developments:

  • In Jun 2022, The US Patent and Trademark Office awarded FriendsLearn a patent for their systems and methods for the digital vaccine. FriendsLearn is the official research partner of the 'digital vaccine initiative' at Carnegie Mellon University in Pittsburgh, United State.FriendsLearn has begun planning for randomised controlled clinical trials (RCT) with the objective of measuring the effects of Digital vaccines combined with Artificial Intelligence on cholesterol, blood glucose, ketones, glycoprotein acetyls, amino acids, and body mass index. 

Competitive Landscape:

Some of the Digital Vaccine market players are:

  • FriendsLearn Inc.,
  • Klein Buendel Inc.
  • Sanofi S.A
  • Evidation Health
  • Atos SE
  • oVRcome 

Market Segmentation:

The digital vaccine market is segmented on the device used and applications. Based on the device used, the market is segmented into smartphones, tablets and others. Based on applications, the digital vaccine market is segmented into covid-19, influenza, diabetes, cardiovascular diseases, hypertension and Others.

Based On device, Smartphone Segment Is A Major Contributor To The Digital Vaccine Market

The market's leading segment is smartphone. Increased adoption of premium smartphone designs, high disposable income, strong internet connectivity use of mobile internet, and an increase in population technological approach are the key drivers of smartphone use. Through ongoing behavioral interventions, smartphone developments in digital vaccinations help deliver many medical diseases at a much-reduced rate.

The Infectious Diseases Segment Witnessed Growth At A Rapid Rate

Infectious Diseases grabbed the highest revenue share and anticipated to continue to hold that position during the forecast time. Increased incidence of infectious diseases, such as hepatitis, influenza, COVID-19, and human immunodeficiency virus, is the primary factor driving the global market expansion. According to mortality surveillance statistics from the National Center for Health Statistics (NCHS) that were available on April 6, 2023, pneumonia, influenza, and/or COVID-19 were responsible for 7.9% of fatalities that occurred during the week ending April 1, 2023 (PIC).

The prevalence of infectious diseases in both developed and developing regions will positively affect market growth. The occurrence of Covid-19 pandemic emerged as a significant market growth factor.

Although typically, vaccine research takes years to complete the necessary testing, governments and medical agencies hastened vaccine development in response to the outbreak's severity. The World Health Organization (WHO) and various government regulatory agencies have launched several initiatives due to the quick advancement of vaccine research.

The North American Digital Vaccine Market Holds A Significant Regional Revenue Share

The North American digital vaccine market is anticipated to register the highest market share, and this is because the region has essential key players and developed healthcare infrastructure. Regional development is anticipated to be fueled by a rising patient base, increased healthcare investment, and government assistance. In addition, Asia Pacific is projected to grow rapidly in the global digital vaccine market because more infectious diseases are emerging, and governments are supporting immunization.

Digital Vaccine Market Report Scope:

Report Attribute

Specifications

Market size value in 2023

USD 1.61 Bn

Revenue forecast in 2031

USD 3.73 Bn

Growth rate CAGR

CAGR of 11.25% from 2024 to 2031

Quantitative units

Representation of revenue in US$ Million, and CAGR from 2024 to 2031

Historic Year

2019 to 2023

Forecast Year

2024-2031

Report coverage

The forecast of revenue, the position of the company, the competitive market statistics, growth prospects, and trends

Segments covered

Heat Source, Component, Plant Type, And Application

Regional scope

North America; Europe; Asia Pacific; Latin America; Middle East & Africa

Country scope

U.S.; Canada; U.K.; Germany; China; India; Japan; Brazil; Mexico; The UK; France; Italy; Spain; Japan; South Korea; Southeast Asia; South Korea

Competitive Landscape

FriendsLearn, Inc., Klein Buendel, Inc., Sanofi S.A., Evidation Health, Inc., and Atos.

Customization scope

Free customization report with the procurement of the report, Modifications to the regional and segment scope. Particular Geographic competitive landscape.

Pricing and available payment methods

Explore pricing alternatives that are customized to your particular study requirements.

Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions

Chapter 2. Executive Summary

Chapter 3. Global Digital Vaccine Market Snapshot

Chapter 4. Global Digital Vaccine Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Investment and Funding Analysis
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Impact of Covid-19 Analysis

Chapter 5. Market Segmentation 1: by Device Estimates & Trend Analysis
5.1. by Device & Market Share, 2023 & 2031
5.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Device:

5.2.1. Smartphones
5.2.2. Tablets
5.2.3. Others

Chapter 6. Market Segmentation 2: by Application Estimates & Trend Analysis
6.1. by Application & Market Share, 2023 & 2031
6.2. Market Size (Value (US$ Mn) & Forecasts and Trend Analyses, 2019 to 2031 for the following by Application:

6.2.1. Hospitals
6.2.2. Ambulatory Care Centers
6.2.3. Specialty Clinics
6.2.4. Others

Chapter 7. Digital Vaccine Market Segmentation 3: Regional Estimates & Trend Analysis

7.1. North America

7.1.1. North America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.1.2. North America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.1.3. North America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.2. Europe

7.2.1. Europe Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.2.2. Europe Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.2.3. Europe Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.3. Asia Pacific

7.3.1. Asia Pacific Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.3.2. Asia Pacific Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.3.3. Asia Pacific Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.4. Latin America

7.4.1. Latin America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.4.2. Latin America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.4.3. Latin America Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

7.5. Middle East & Africa

7.5.1. Middle East & Africa Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Device, 2023-2031
7.5.2. Middle East & Africa Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by Application, 2023-2031
7.5.3. Middle East & Africa Digital Vaccine Market Revenue (US$ Million) Estimates and Forecasts by country, 2023-2031

Chapter 8. Competitive Landscape

8.1. Major Mergers and Acquisitions/Strategic Alliances

8.2. Company Profiles


8.2.1. FriendsLearn Inc.,
8.2.2. Klein Buendel Inc.
8.2.3. Sanofi S.A
8.2.4. Evidation Health
8.2.5. Atos SE
8.2.6. oVRcome
8.2.7. Other Prominent Players

Segmentation of Digital Vaccine Market-

Digital Vaccine Market By Device Used:

  • Smartphones
  • Tablets
  • Others

https://www.insightaceanalytic.com/images_data/393652008.JPG

Digital Vaccine Market By Application:

  • Diabetes
  • Infectious Diseases
  • Cardiovascular Diseases
  • Others

Digital Vaccine Market By Region-

North America-

  • The US
  • Canada
  • Mexico

Europe-

  • Germany
  • The UK
  • France
  • Italy
  • Spain
  • Rest of Europe

Asia-Pacific-

  • China
  • Japan
  • India
  • South Korea
  • South East Asia
  • Rest of Asia Pacific

Latin America-

  • Brazil
  • Argentina
  • Rest of Latin America

 Middle East & Africa-

  • GCC Countries
  • South Africa
  • Rest of Middle East and Africa

InsightAce Analytic follows a standard and comprehensive market research methodology focused on offering the most accurate and precise market insights. The methods followed for all our market research studies include three significant steps – primary research, secondary research, and data modeling and analysis - to derive the current market size and forecast it over the forecast period. In this study, these three steps were used iteratively to generate valid data points (minimum deviation), which were cross-validated through multiple approaches mentioned below in the data modeling section.

Through secondary research methods, information on the market under study, its peer, and the parent market was collected. This information was then entered into data models. The resulted data points and insights were then validated by primary participants.

Based on additional insights from these primary participants, more directional efforts were put into doing secondary research and optimize data models. This process was repeated till all data models used in the study produced similar results (with minimum deviation). This way, this iterative process was able to generate the most accurate market numbers and qualitative insights.

Secondary research

The secondary research sources that are typically mentioned to include, but are not limited to:

  • Company websites, financial reports, annual reports, investor presentations, broker reports, and SEC filings.
  • External and internal proprietary databases, regulatory databases, and relevant patent analysis
  • Statistical databases, National government documents, and market reports
  • Press releases, news articles, and webcasts specific to the companies operating in the market

The paid sources for secondary research like Factiva, OneSource, Hoovers, and Statista

Primary Research:

Primary research involves telephonic interviews, e-mail interactions, as well as face-to-face interviews for each market, category, segment, and subsegment across geographies

The contributors who typically take part in such a course include, but are not limited to: 

  • Industry participants: CEOs, CBO, CMO, VPs, marketing/ type managers, corporate strategy managers, and national sales managers, technical personnel, purchasing managers, resellers, and distributors.
  • Outside experts: Valuation experts, Investment bankers, research analysts specializing in specific markets
  • Key opinion leaders (KOLs) specializing in unique areas corresponding to various industry verticals
  • End-users: Vary mainly depending upon the market

Data Modeling and Analysis:

In the iterative process (mentioned above), data models received inputs from primary as well as secondary sources. But analysts working on these models were the key. They used their extensive knowledge and experience about industry and topic to make changes and fine-tuning these models as per the product/service under study.

The standard data models used while studying this market were the top-down and bottom-up approaches and the company shares analysis model. However, other methods were also used along with these – which were specific to the industry and product/service under study.

To know more about the research methodology used for this study, kindly contact us/click here.

user icon
office icon
mail icon
call icon

This website is secure, and we do not share your personal information with any third party. Privacy Policy

Need Customization
Need specific information/chapter from the report of the custom data table, graph or complete report? Tell us more.

Frequently Asked Questions

How big is the Digital Vaccine Market?

Digital Vaccine Market expected to grow at a 11.25% CAGR during the forecast period for 2024-2031

FriendsLearn, Inc., Klein Buendel, Inc., Sanofi S.A., Evidation Health, Inc., and Atos

Our Clients

  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo
  • client logo

Media Citations

  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo
  • media citation logo

Growth opportunities and latent adjacency in Healthcare IT

Select Licence Type
$4456
$7786
$10000
$1200
Get Your GTM Strategy

Navigate market entry with channel selection, launch strategy & timeline, and pricing model support.

Equip yourself with the insights needed to develop a winning go-to-market strategy

Get real-time updates and joint control over project direction with our collaborative approach